Response to Stable Supply and Business Continuity During an Infectious Disease Outbreak
First written in FY2020. 3 of 4 entries say "Advanced", first in FY2021-Q1. Latest entry: FY2022-Q1.
The whole theme swung hardest in 2026: 1 of 12 companies on the "Worse" side.
28 other companies' latest entry also says "Advanced".
- FY2022-Q1AdvancedAnnual report
「To reduce the burden on local communities and accelerate COVID-19 vaccinations, we conducted workplace vaccinations for our employees and their associates from June through July under a vaccination framework centered on our occupational physicians, in accordance with the government’s announced policy.」
Business continuity and infection prevention measures were made concrete through workplace vaccinations conducted from June to July 2021. - FY2021-Q2AdvancedAnnual report
「Under these circumstances, our Group implemented measures to prevent COVID-19 infections inside and outside the company, ensure employee safety and fulfill our responsibility to supply products. We continued business operations by rigorously managing employee health and attendance and using group-based work arrangements, telework and flextime systems to enhance organizational redundancy. To secure the supply chain, we also increased inventories of raw materials and supplies to specified levels and built up inventories of domestically manufactured products, thereby enhancing our capacity to supply products and maintain business continuity in the event of unforeseen circumstances.」
In addition to the existing infection prevention measures and work arrangements, we enhanced organizational redundancy and increased inventories of raw materials, supplies and domestically manufactured products, thereby increasing product supply capacity and business continuity. - FY2021-Q1AdvancedAnnual report
「Under these circumstances, our Group made the prevention of COVID-19 infections inside and outside the company, ensuring employee safety and compliance with various requests from national and local governments its highest management priorities. In addition, to fulfill our responsibility as a medical device manufacturer to supply products to the greatest extent possible, we placed the highest priority on securing manufacturing and logistics functions, thoroughly managed the health and attendance of employees engaged in these functions, and continued business operations while using group-based work arrangements, telework and flextime systems.」
To prevent infections, ensure safety and maintain stable supply, we continued business operations while managing employee health and attendance and using group-based work arrangements, telework and flextime systems. - FY2020First statedAnnual report
「We have continued normal business operations in product supply while using group-based shift work, telework and flexible commuting arrangements.」
This is the first explicit statement of measures to maintain a stable supply of medical devices through shift work, telework and flexible commuting arrangements while preventing infections and ensuring employee safety.